<DOC>
	<DOCNO>NCT00609843</DOCNO>
	<brief_summary>Rationale : Bladder tumour often visible X-ray base image-modalities plan treatment Radiotherapy . Purpose : To determine single contrast ( Lipiodol ) demarcation bladder tumour treatment feasible visible multiple X-ray base image-modalities Radiotherapy .</brief_summary>
	<brief_title>Pilot Studie Lipiodol Demarcation Tumour Bladder Cancer</brief_title>
	<detailed_description>To exploit potential modern Radiotherapy ( RT ) , important localize follow target precisely treatment . Since bladder tumour usually identify conventional CT-scan , fiducial contrast mark system warrant . The iodized oil , Lipiodol well-known contrast medium use mainly lymphography Hysterosalpingography . Local Lipiodol demarcation use localisation tumour lung , prostate seminal vesicle visualise Computed Tomography ( CT ) fluoroscopy . Purpose : To evaluate feasibility tumour demarcation use contrast agent Lipiodol adaptive Image-guided RT bladder cancer . Visibility CT , Cone-Beam CT , MRI on-board imaging evaluate .</detailed_description>
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<mesh_term>Ethiodized Oil</mesh_term>
	<criteria>Histologically confirm primary muscle invasive transitional cell carcinoma Bladder . T14a , N01 , M0 . Nonoperable refuse operation . Eligible curative Radiotherapy . Oral write informed consent . Fertile woman must negative pregnancy test inclusion use contraceptive pill intrauterine device . Ongoing beta blocker treatment pause Lipiodol injection . Known metabolic disorder ( hyperthyroidism , goiter ) Allergy towards iodine . Pregnancy / breastfeed Performance status ECOG &gt; 2</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2009</verification_date>
	<keyword>Bladder cancer</keyword>
	<keyword>Radiotherapy</keyword>
	<keyword>Tumour delineation</keyword>
	<keyword>Markers</keyword>
</DOC>